Study to access safety of Durvalumab in Indian adult patients with locally advanced NSCLC

Trial Identifier: D133HC00003
Sponsor: AstraZeneca
NCTID:: NCT04416633
Start Date: November 2021
Primary Completion Date: October 2023
Study Completion Date: October 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Bengali Translation
Kannada Translation
Oriya Translation
Marathi Translation
Hindi Translation
Malayalam Translation
Punjabi Translation
Tamil Translation
Gujarati Translation
Telugu Translation

Trial Locations

Country Location
IN Bangalore, IN, 560017
IN Bangalore, IN, 560022
IN Delhi, IN, 110029
IN Delhi, IN, 110085
IN Faridabad, IN, 121001
IN Gurgaon, IN, 122001
IN Kolkata, IN, 700160
IN Mohali, IN, 160055
IN Mumbai, IN, 400012
IN Mumbai, IN, 400053
IN Mumbai, IN, 400056
IN New Delhi, IN, 110005